Irene Vanni

The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients

Maria Giovanna Dal Bello, Rosangela Filiberti, Angela Alama et al. · Journal of Translational Medicine · 2019 · 193 citations · Full text

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer

Selene Ottonello, Carlo Genova, Irene Cossu et al. · Frontiers in Immunology · 2020 · 108 citations · Full text

Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: ¹⁸F-FDG PET/CT Study

Silvia Morbelli, Angela Alama, Giulia Ferrarazzo et al. · Journal of Nuclear Medicine · 2017 · 50 citations · Full text

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

Simona Coco, Angela Alama, Irene Vanni et al. · International Journal of Molecular Sciences · 2017 · 50 citations · Full text

Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine

Simona Coco, Anna Truini, Irene Vanni et al. · Current Drug Targets · 2014 · 49 citations

Engineering, Pathology, Sanger Sequencing +17